Derek Hicks

NTLA

Derek Hicks serves as EVP, Chief Business Officer at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$260.8K

Net Position

Net Seller

$260.8K

Companies Traded

NTLA

Active Period

Jan 2023 – Jan 2025

3 total trades

Most Recent

Sell NTLA

Jan 7, 2025 · $79.2K

Derek Hicks's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

0 · $0.00

Sells

3 · $260.8K

Total Shares Bought

Total Shares Sold

12,191

NTLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 7, 2025	Sell	6,502	$12.18	$79.2K	59,878
Jan 5, 2024	Sell	3,877	$29.46	$114.2K	36,987
Jan 6, 2023	Sell	1,812	$37.21	$67.4K	17,306

Related Insiders

Eliana Clark

officer: EVP, Chief Technical Officer

NTLASell · Mar 3, 2026

BASTA JAMES

officer: EVP, General Counsel

NTLASell · Mar 3, 2026

Michael P Dube

VP, Chief Accounting Officer

NTLASell · Jan 5, 2026

Edward J Dulac III

EVP, Chief Financial Officer

NTLASell · Jan 5, 2026

Birgit C Schultes

EVP, Chief Scientific Officer

NTLASell · Jan 5, 2026

Fred E Cohen

Director

NTLABuy · Jan 5, 2026

David Lebwohl

EVP, Chief Medical Officer

NTLASell · Jan 5, 2026

LEONARD JOHN M

President and CEO

NTLASell · Jan 5, 2026

Explore More Insider Trading Data

NTLA Insider Trading Activity

View all insider trades at Intellia Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity